This analysis confirmed the higher levels of antithrombin III, angiotensinogen and α-1-antitrypsin in non-relapsing HL plasma, and of fibronectin in relapsing HL plasma (Figure 1). This evidence concerns the gene FN1 and Hodgkins lymphoma.